Current status and future applications of cellular therapies for cancer. - Wikidata - wikimedia - TriplyDB

Current status and future applications of cellular therapies for cancer.

Current status and future applications of cellular therapies for cancer.

http://www.wikidata.org/entity/Q37861216

about

Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies Overcoming tumor immune evasion with an unique arbovirus Improved cytotoxic T-lymphocyte immune responses to a tumor antigen by vaccines co-expressing the SLAM-associated adaptor EAT-2.Supernatants from lymphocytes stimulated with Bacillus Calmette-Guerin can modify the antigenicity of tumours and stimulate allogeneic T-cell responses.Human induced pluripotent stem cells from basic research to potential clinical applications in cancer Mature dendritic cell derived from cryopreserved immature dendritic cell shows impaired homing ability and reduced anti-viral therapeutic effects.Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.Exploiting dendritic cells in the development of cancer vaccines.Human iPSC-derived mesenchymal stem cells encapsulated in PEGDA hydrogels mature into valve interstitial-like cells.

P2860

Q26752558-FB5F0C93-1925-491D-AE94-A5ED572029C5 Q28081774-9D838A20-BAB4-4D58-A104-B3386B0F6FF3 Q34080911-CE099CCE-E28D-472C-9945-44F221280F25 Q35287568-A1F3F235-FA15-4A03-928B-1A93F5B4E746 Q37316328-28EA8C10-B657-4D6B-A751-FCD7E40771F2 Q37497528-68F28132-6095-4262-A9B0-5F25DC71E070 Q38031222-CCEFF7D1-E68D-43E4-A94A-E2F1ACB4065E Q38148774-34A23EA8-710E-4A7D-93E8-1F33FDB3FA50 Q52673819-971738D6-E69D-49C5-8158-F68D30E581F9

P2860

Current status and future applications of cellular therapies for cancer.

http://www.wikidata.org/entity/Q37861216

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current status and future applications of cellular therapies for cancer.

@en

Current status and future applications of cellular therapies for cancer.

@nl

type

label

Current status and future applications of cellular therapies for cancer.

@en

Current status and future applications of cellular therapies for cancer.

@nl

prefLabel

Current status and future applications of cellular therapies for cancer.

@en

Current status and future applications of cellular therapies for cancer.

@nl

P1433

Q37861216-F5614725-37D1-46A3-B6BC-ABAB8A43FC1D

P1476

Q37861216-6FDCB88E-6146-4BE6-8D23-F4E496E355C7

P2093

Q37861216-3B42D467-9C64-43B4-96F3-485C771F984A

Q37861216-7A9C10A4-3395-466E-B0FD-5288F7731A02

Q37861216-B555743F-8762-46CD-A6BE-DFDDACE4E2F4

P2860

Q37861216-0089ABDF-49CF-44EC-A628-999C7BB50B4B

Q37861216-0B32088A-055D-4673-875E-2543229D4484

Q37861216-17D0DB19-2087-43CF-8296-EB455706E8E1

Q37861216-18EF4593-17B3-45CB-90A1-095E59410F97

Q37861216-1E9CCBCF-0DDC-4EB3-A752-4AB574497A33

Q37861216-21714E3C-17A2-4BFE-9A8B-4D3DD08031DF

Q37861216-225AE601-59D6-4292-A7BF-6EA595BBB3A9

Q37861216-2353E3DC-3E00-4102-B983-969D6C97FE23

Q37861216-25ABAA49-E7DE-4D5B-9B4E-66F33D9E0473

Q37861216-25E31F74-0C3E-4209-A798-7E62D4DF9E68

P304

Q37861216-F4E4550A-FEE5-4E1B-882E-00826A42A83C

P31

Q37861216-03C3C994-B43B-4352-8FA7-3D16CA20E600

P356

Q37861216-73139815-27A2-49AC-AFE0-5221E5A08B23

P433

Q37861216-37676235-409B-44B0-830B-54B98FC18798

P478

Q37861216-2928C845-C104-40C9-B0B0-89AF45BB7019

P577

Q37861216-F5D2057E-5E28-4E92-9589-AC902680CC2E

P698

Q37861216-EFF0CC87-985E-4F80-B3E6-44FB022442E6

P356

P1433

P1476

Current status and future applications of cellular therapies for cancer.

@en

P2093

Angus Dalgleish

http://www.w3.org/2001/XMLSchema#string

John Copier

http://www.w3.org/2001/XMLSchema#string

Mark Bodman-Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Cancer regression in patients after transfer of genetically engineered lymphocytes

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma.

P304

507-516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT.11.18

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21463192

http://www.w3.org/2001/XMLSchema#string